Your browser doesn't support javascript.
loading
Identification of a New Class of Selective Excitatory Amino Acid Transporter Subtype 1 (EAAT1) Inhibitors Followed by a Structure-Activity Relationship Study.
Hansen, Stinne W; Erichsen, Mette N; Fu, Bingru; Bjørn-Yoshimoto, Walden E; Abrahamsen, Bjarke; Hansen, Jacob C; Jensen, Anders A; Bunch, Lennart.
Afiliação
  • Hansen SW; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Erichsen MN; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Fu B; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Bjørn-Yoshimoto WE; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Abrahamsen B; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Hansen JC; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Jensen AA; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
  • Bunch L; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Universitetsparken 2, Copenhagen Ø 2100, Denmark.
J Med Chem ; 59(19): 8757-8770, 2016 10 13.
Article em En | MEDLINE | ID: mdl-27626828
Screening of a small compound library at the three excitatory amino acid transporter subtypes 1-3 (EAAT1-3) resulted in the identification of compound (Z)-4-chloro-3-(5-((3-(2-ethoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid (1a) that exhibited a distinct preference as an inhibitor at EAAT1 (IC50 20 µM) compared to EAAT2 and EAAT3 (IC50 > 300 µM). This prompted us to subject 1a to an elaborate structure-activity relationship study through the purchase and synthesis and subsequent pharmacological characterization of a total of 36 analogues. Although this effort did not result in analogues with substantially improved inhibitory potencies at EAAT1 compared to that displayed by the hit, it provided a detailed insight into structural requirements for EAAT1 activity of this scaffold. The discovery of this new class of EAAT1-selective inhibitors not only supplements the currently available pharmacological tools in the EAAT field but also substantiates the notion that EAAT ligands not derived from α-amino acids hold considerable potential in terms of subtype-selective modulation of the transporters.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Benzoatos / Transportador 1 de Aminoácido Excitatório / Furanos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Benzoatos / Transportador 1 de Aminoácido Excitatório / Furanos Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article